308080ViGenCell308080 info
$2.78info2.65%24h
Global rank24885
Market cap$53.01M
Change 7d-7.87%
YTD Performance-37.54%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    ViGenCell (308080) Stock Overview

    ViGenCell Inc. specializes in immune cell therapy. It develops ViTier, a T-cell therapy platform that uses antigen-specific killer T cells to target and remove cancer cells; ViRanger, a T-cell gene therapy platform that uses innate killer T cells to target and eliminate abnormal cells; and ViMedier, an immunosuppressive cell therapy platform that uses the differentiation and expansion of cord blood derived myeloid suppressor cells for universal use. The company was founded in 1995 and is based in Seoul, South Korea.

    308080 Stock Information

    Symbol
    308080
    Address
    Annex Building Seoul St. Mary’s HospitalSeoul, South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.vigencell.com
    Country
    🇰🇷 South Korea
    Phone Number
    82-2-3478-1685

    ViGenCell (308080) Price Chart

    -
    Value:-

    ViGenCell Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.78
    N/A
    Market Cap
    $53.01M
    N/A
    Shares Outstanding
    19.08M
    N/A
    Employees
    74.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org